Clinical trial
Treatment With Octreotide in Patients With Lymphangioleiomyomatosis
NCT00005906 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00005906 |
|---|---|
| Title | Treatment With Octreotide in Patients With Lymphangioleiomyomatosis |
| Official title | Treatment With Octreotide in Patients With Lymphangioleiomyomatosis |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphangioleiomyomatosis, Lymphangiomyomas, Pleural Effusions, Ascites |
| Intervention type | Drug |
| Interventions | Octreotide |
| Enrollment | 4 |
| Start date | Jun 1, 2000 |
| Primary completion | Apr 1, 2008 |
| First posted | Jun 12, 2000 |
| Last update posted | Apr 30, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: